What it is
Regulatory status: prescription medication
Mechanism evidence: human
At a glance
What it is, why people use it, the evidence, and what to know before trying it.
Why people use it
- Lower LDL cholesterol
- Reduce cardiovascular risk in eligible statin-intolerant adults through the bempedoic-acid component
Evidence at a glance
Nexlizet is an evidence-based prescription LDL-lowering combination for defined patients, not a general supplement. Benefit and risk depend on baseline cardiovascular risk, statin tolerance, uric acid, tendon risk, and current labeling.
Confidence: strong
Clinical safety
Contraindications, interactions and clinical cautions from reviewed sources.
Important risks include hyperuricemia, gout, tendon rupture, and gallstones. Interactions and indication details must be checked against the current label and the patient's other lipid medicines.
- serious hypersensitivity to either component
- simvastatin
- pravastatin
Forms and variants
This review does not automatically apply to:
- bempedoic acid alone
- ezetimibe alone
- statins
- older Nexlizet labels with narrower indications
Seen in protocols
Public protocols that include Nexlizet. Open one to see the full context and source.